Dr. Laura Ragmanauskaite, MD

Dr. Ragmanauskaite practices at Peachtree Dermatology Associates in Atlanta, Georgia.

Dr. Ragmanauskaite's NPI, 1457877698, was assigned on August 18, 2017. Dr. Ragmanauskaite graduated from Emory University School of Medicine in 2020. Dr. Ragmanauskaite holds Georgia license 99315.

Dr. Ragmanauskaite's primary practice is Peachtree Dermatology Associates, at 371 E Paces Ferry NE Rd, Atlanta, GA 30305 in Fulton County. The practice phone is (404) 355-1919.

Dr. Ragmanauskaite's primary practice is Peachtree Dermatology Associates in Atlanta, Georgia. The medical group on file is Peachtree Dermatology Associates. Dmand AI also links Dr. Ragmanauskaite to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ragmanauskaite practices. Vendor and product names are available with a free account.

Dermatology is Dr. Ragmanauskaite's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Ragmanauskaite is licensed in Georgia.

CMS data shows 49 Medicare services from Dr. Ragmanauskaite across 3 procedure codes in 2024, for 44 Medicare patients. Medicare paid $2,862 for them. Every service was in an office.

CMS counts 44 Medicare patients who saw Dr. Ragmanauskaite in 2024. The largest group is 65 to 74, with 23 patients. 73% of them have high cholesterol, and 43% have high blood pressure. Their average risk score is 0.80, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ragmanauskaite's median patient age at 57, with 54% women.

In 2024, Dr. Ragmanauskaite wrote 156 Medicare Part D claims for 60 patients. 63% of them were for generic drugs. CMS names the drug for 76 of them, across 5 drugs with 11 or more claims each, at $95,864 in total drug cost. In 2023, CMS named 168 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Ragmanauskaite for performance year 2024, reported as part of a group. Dr. Ragmanauskaite accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 99 procedures of melanoma (skin cancer) excision by Dr. Ragmanauskaite, more than 93% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 5 papers to Dr. Ragmanauskaite, published from 2019 to 2020. 2020 was the busiest year, with 3. The most frequent topics are Transgender Persons, Acne Vulgaris and Motivation. Dr. Ragmanauskaite's most frequent co-authors are Michael Goodman, MD, Michael Silverberg, MD and Meera Brahmbhatt, MD.

CMS Open Payments shows 100 general payments to Dr. Ragmanauskaite from 19 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 95% of the total. Abbvie Inc. paid the most, $554.

Dr. Ragmanauskaite graduated from Emory University School of Medicine in 2020.